NCT03516812 2025-09-29
Testosterone and Olaparib in Treating Patients With Castration-Resistant Prostate Cancer
University of Washington
Phase 2 Completed
Clinical Trials
3 trialsNCT05479578 2025-01-08
Cyclophosphamide and Dexamethasone for the Treatment of Metastatic Castration Resistant Prostate Cancer
University of California, Davis
Phase 1 Active not recruiting
NCT04951492 2025-01-01
Olaparib for the Treatment of Castration Resistant Prostate Adenocarcinoma
University of Washington
Phase 2 Terminated